BMV: Health Canada clarification on stabs [Bioanalytics]

posted by Ohlbe – France, 2015-10-12 00:34 (3414 d 05:07 ago) – Posting: # 15553
Views: 5,744

Dear ElMaestro,

❝ Am I right in thinking the implication is that n indepently prepared spiking (parent) solutions need to be produced if we want n replicates of the experiment?


I would say no. They say that
[...] it provides limited (i.e., N = 1) information regarding the effects of the storage conditions on accuracy and no information on the effects of the conditions on the variability of the drug concentration.

Having n preparations from n spiking solutions would only add the variability of the preparation, not information on the effects of the storage condition.

They also later say regarding insufficient data that
In these cases, an amendment to the validation report will be requested that includes stability experiments conducted using sets of low and high QC samples aliquoted prior to the stability experiment and all samples subjected to the given stability conditions independently prior to processing.

My understanding is 1 aliquot from each of n tubes from the same bulk spiking (but not n aliquots taken from a single tube after thawing the stability sample).

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
88 visitors (0 registered, 88 guests [including 13 identified bots]).
Forum time: 04:41 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5